Mesenbio is a preclinical biopharmaceutical business based at the University of York.
Mesenbio has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Mesenbio's investors include Innovate UK, DSW Ventures, NG Bio.
Mesenbio is headquartered in Newyork, United Kingdom.
Mesenbio is a preclinical biopharmaceutical business based at the University of York.
Mesenbio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mesenbio — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/mesenbio. Accessed August 14, 2026.
VCBacked. (2024). Mesenbio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mesenbio
{{cite web |title=Mesenbio — Funding & Investors |url=https://www.vcbacked.co/company/mesenbio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated